Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
GeneCraft Logo
GeneCraft Growth Score
87
CB Rank
92641
Heat Score
37
GeneCraft specializes on improving treatment and clinical outcomes for patients using gene therapy.
Founded
obfuscation
PrivateGrant Seongnam, Kyonggi-do, South Korea11-50 www.genecraft.co.kr
Biopharma
Biotechnology
Medical
Overview

GeneCraft
Total Funding
obfuscation
Growth Score
87
Heat Score
37

Total Funding
obfuscation
Grant raised
obfuscation
Growth Score87
-2 pts
in past quarter
Heat Score 37
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About GeneCraft

CB Rank
92641
GeneCraft specializes on improving treatment and clinical outcomes for patients using gene therapy.
Founded
obfuscation
PrivateGrant Seongnam, Kyonggi-do, South Korea11-50 www.genecraft.co.kr
Biopharma
Biotechnology
Medical

Funding Rounds

Grant
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Details

Legal Name Genecraft Co., Ltd.
Also Known As 진크래프트, Jincraft Co., Ltd.
Operating Status Active
Company Type For Profit
About the Company
GeneCraft specializes on improving treatment and clinical outcomes for patients using gene therapy.
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

RX001
A gene therapy drug candidate targeting Pan K-RAS mutated lung cancer by selectively inducing death in abnormal cancer cells.
Ubi-AAV Platform
A gene therapy platform that enables the development of new gene therapeutics by crafting gene contents into viral vectors.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - GeneCraft Logo
Grant - GeneCraft
1
obfuscation
Scaleup TipsGrant
obfuscation
Grant - GeneCraft Logo
Grant - GeneCraft
1
obfuscation
Scaleup TipsGrant
obfuscation
Grant - GeneCraft Logo
Grant - GeneCraft
1
obfuscation
Scaleup TipsGrant
obfuscation
Grant - GeneCraft Logo
Grant - GeneCraft
1
obfuscation
Scaleup TipsGrant
obfuscation
Grant - GeneCraft Logo
Grant - GeneCraft
1
obfuscation
Scaleup TipsGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - GeneCraft Logo
Grant - GeneCraft
1
obfuscation
Scaleup TipsGrant
obfuscation
Grant - GeneCraft Logo
Grant - GeneCraft
1
obfuscation
Scaleup TipsGrant
obfuscation
Grant - GeneCraft Logo
Grant - GeneCraft
1
obfuscation
Scaleup TipsGrant
obfuscation
Grant - GeneCraft Logo
Grant - GeneCraft
1
obfuscation
Scaleup TipsGrant
obfuscation
Grant - GeneCraft Logo
Grant - GeneCraft
1
obfuscation
Scaleup TipsGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Scaleup Tips Logo
Scaleup Tips
Yes
Grant - GeneCraft Logo
Grant - GeneCraft
—
Scaleup Tips Logo
Scaleup Tips
Yes
Grant - GeneCraft Logo
Grant - GeneCraft
—
Scaleup Tips Logo
Scaleup Tips
Yes
Grant - GeneCraft Logo
Grant - GeneCraft
—
Scaleup Tips Logo
Scaleup Tips
Yes
Grant - GeneCraft Logo
Grant - GeneCraft
—
Scaleup Tips Logo
Scaleup Tips
Yes
Grant - GeneCraft Logo
Grant - GeneCraft
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News
Technology
View Tech Report

Monthly Web Visits

104
57.58%
 in past month

Active Website Tech Count

2GeneCraft is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 50m.

Total IP

1GeneCraft has 1 registered trademark in the 'Pharmaceutical, veterinary and sanitary products' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is GeneCraft's headquarters? GeneCraft is located in Seongnam, Kyonggi-do, South Korea.Who invested in GeneCraft? GeneCraft has 5 investors including Scaleup Tips and  Korea Venture Investment Corp.When was the last funding round for GeneCraft? GeneCraft closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are GeneCraft's competitors? Alternatives and possible competitors to GeneCraft may include Vyriad, Asklepios BioPharmaceutical, and  Replimune Group.How much funding has GeneCraft raised to date? GeneCraft has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f8e1fc8 1)
|